News

The orphan medicinal product designation provides Phytopharm with market exclusivity in the EU for 10 years following Myogane’s market authorization. In addition to the 10 year market exclusivity,

Funds will be used for the development of the company’s pipeline in treatments for Alzheimer’s and other neurodegenerative diseases, such as Parkinson’s and Huntington’s disease. Geoffrey Kempler, chairman

India’s Drugs Controller General (DCGI), Surinder Singh, said that he did not intend to approve marketing applications for cut-price generic versions of drugs that have a patent in

Despite the low growth rate of global pharma market, the sales of cancer drugs are predicted to outpace the pharma market owing to the increasing patient population in

As part of the civil resolution of these investigations, Merck has agreed to pay a total of $58 million to be divided among the 29 states and the

Many of these agreements, which are for a term of one year, were signed with several of the company’s top 10 distributors from 2007. Newly engaged distributors include

Entereg is indicated to accelerate upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. Entereg will be available for short-term use

This Yag laser wavelength system is said to treat a wide array of dermatological and aesthetic conditions by photo-acoustical removal of epidermal and dermal pigmented lesions including all

Under the terms of the agreement, Penwest will receive undisclosed fees and payments. Jennifer Good, president and CEO of Penwest, said: “These arrangements fit with our strategy of